P11-4 vs Clavanin A
Head-to-head comparison of P11-4 (Self-assembling peptide P11-4 (Ac-QQRFEWEFEQQ-NH2)) and Clavanin A (Clavanin A (tunicate-derived antimicrobial peptide)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | P11-4 | Clavanin A |
|---|---|---|
| Category | Dental & Oral | Marine-Derived |
| Full Name | Self-assembling peptide P11-4 (Ac-QQRFEWEFEQQ-NH2) | Clavanin A (tunicate-derived antimicrobial peptide) |
| Molecular Weight | 1466 Da | ~2.6 kDa |
| Half-Life | local activity for hours; peptide degraded over time | NR |
| Amino Acids | 11 | 23 |
| Typical Dose | 0.5-5 mg per lesion | NR |
| Route | Topical/Intraoral | in vitro|topical preclinical |
| Purity | ≥98% | ≥98% |
| Studies Count | 40 | 83 |
| Research Status | Clinical | Pre-clinical |
P11-4 Benefits
- ✓enamel remineralization
- ✓early caries arrest
- ✓biomimetic scaffold formation
- ✓minimally invasive repair
Clavanin A Benefits
- ✓antibacterial
- ✓anti-inflammatory
- ✓wound-healing lead
P11-4 Dosing
topical application to cleaned lesion|single-visit in-office application|repeat at follow-up if indicated
Clavanin A Dosing
NR|NR
P11-4 Side Effects
- ⚠transient tooth sensitivity
- ⚠local irritation
- ⚠taste disturbance
Clavanin A Side Effects
- ⚠hemolysis at high concentrations
- ⚠immunogenicity risk
- ⚠protease sensitivity
Research Overview
P11-4
P11-4 has been studied for its ability to penetrate initial carious lesions and self-assemble into a fibrillar matrix that nucleates hydroxyapatite. Human and preclinical studies support its role in non-invasive enamel repair.
Clavanin A
Preclinical work supports broad antibacterial activity and some host-modulating effects, especially in skin and wound models. Activity can be improved through sequence optimization and formulation strategies.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.